@article{89be7e964fd4438686e153a1a96d9d6c,
title = "Dipeptidyl Peptidase-4 Inhibitors and Beta Cell Mass in Japanese Adults with Type 2 Diabetes",
author = "Hironobu Sasaki and Yoshifumi Saisho and Hiroshi Itoh",
note = "Funding Information: We thank Taketo Yamada and Yuko Madokoro (Department of Pathology, Keio University School of Medicine) for technical assistance, and Dr Wendy Gray (self-employed, London, United Kingdom) for editing the manuscript. This study was supported by funding from the Japan Diabetes Foundation, Japan , Keio Gijuku Academic Development Funds, and a Grant-in-Aid for Scientific Research (21K08535) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Funding Information: We thank Taketo Yamada and Yuko Madokoro (Department of Pathology, Keio University School of Medicine) for technical assistance, and Dr Wendy Gray (self-employed, London, United Kingdom) for editing the manuscript. This study was supported by funding from the Japan Diabetes Foundation, Japan, Keio Gijuku Academic Development Funds, and a Grant-in-Aid for Scientific Research (21K08535) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Dr Saisho received honoraria from Sumitomo Dainippon Pharma Co. Dr Itoh received grants and honoraria from Shionogi & Co, Nippon Boehringer Ingelheim, MSD KK, Daiichi Sankyo, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Corp, Taisho Toyama Pharmaceutical, and Shionogi & Co; grants from Astellas Pharma, Sumitomo Dainippon Pharma Co, Teijin Pharma, Kyowa Hakko Kirin, Mochida Pharmaceutical Co, Chugai Pharmaceutical, Ono Pharmaceutical Co, and Eli Lilly and Company, Japan KK; and personal fees from SBI Pharmaceuticals Co and Nipro Corp.",
year = "2022",
month = may,
doi = "10.1016/j.eprac.2022.02.001",
language = "English",
volume = "28",
pages = "563--564",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "5",
}
